Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news

Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building out a full-scale AI clinical assistant. | Abridge…

The new round values the physical AI startup that aims to automate heavy engineering and drug design at $41 billion.